Taking a traditional psychedelic substance together with a romantic partner is associated with a deeper sense of mutual understanding and enhanced relationship quality. In contrast, using these substances alone might leave partners out of sync, potentially contributing to relationship dissolution down the line. The new research highlighting these relational dynamics was recently published in the Journal of Psychoactive Drugs.
In psychology, people are believed to make sense of themselves and the broader world through their relationships with others. Romantic partners are particularly motivated to develop a joint perspective on life, actively aligning their views to create a stable social environment. Researchers refer to this psychological phenomenon as shared reality. When a couple possesses a high degree of this mutual perspective, they understand external events in a very similar way.
This mutual understanding builds trust and reinforces the underlying bond between the two individuals. A strong shared reality often develops simply by experiencing mundane life events together over a long period of time, such as eating meals, dealing with hardships, or taking a walk.
A psychedelic experience, however, is an entirely different type of event. It is a powerfully transformative state that alters a person’s sensory perception, emotional regulation, and cognitive processing. Because these profound neurological shifts are entirely internal, they are completely invisible to an outside observer.
When only one member of a couple takes a substance like psilocybin or LSD, the experience cannot be directly observed or felt by their sober partner. Following the drug’s effects, the two individuals might emerge with contrasting perceptions of reality. Having mismatched perceptions of reality is known to damage relationship quality and breed emotional distance over time.
Most research in modern health psychology has focused heavily on the individual patient, treating mental health as an isolated, internal struggle. Scientific investigations into psychedelic therapies have mostly favored this individualistic approach, largely ignoring the social environment the patient will return to. Yet, observational studies on group-based psychedelic ceremonies show that social processes serve as a major catalyst for healing.
Concepts like emotional support and a perceived sense of shared humanity help translate the chaotic psychedelic experience into lasting psychological improvements. This mirrors evidence in general behavioral health showing that lifestyle interventions, such as quitting smoking, often work better when they target households rather than individuals.
Therapies utilizing substances that are not considered classic psychedelics are already incorporating relational frameworks. Novel treatments using MDMA to address trauma have shown positive behavioral outcomes when partners are included in the process. Similarly, the drug ketamine is being integrated into couple-oriented therapeutic interventions, showing promise for enduring improvements in empathy, emotional vulnerability, and perspective-taking.
Talea Cornelius, a researcher at Columbia University Irving Medical Center, and Tommaso Barba, a researcher at Imperial College London, wanted to understand how social context shapes outcomes for classic serotonergic psychedelics. They suspected that sharing an intense, perspective-altering journey might yield profound relational benefits for a romantic pair. They also theorized that leaving a partner out of the experience could create a psychological rift.
To test these ideas, Cornelius and Barba designed an online survey to capture relationship dynamics before and after a psychedelic event. They recruited adults who had previously taken a moderate to strong dose of a classic psychedelic. The study participants had to be in a romantic relationship at the time of the drug use, though they could report on either a past or current union.
The researchers gathered information from nearly eight hundred participants. Within this group, a small subset of couples participated together utilizing unique identification codes to link their surveys anonymously. The bulk of the respondents participated as individuals without their partners but still provided detailed reports on their relationship dynamics.
Participants reflected on their single most meaningful psychedelic event involving a traditional substance. A traditional psychedelic refers to compounds that primarily alter perception by interacting with the serotonin system in the brain. The researchers noted that almost half of the sample reported using psilocybin, while just over a quarter used LSD, and others opted for substances containing DMT.
To quantify the abstract concept of mutual understanding, the survey utilized a specialized psychological questionnaire. Participants rated their agreement with statements regarding the specific psychedelic session. For example, they were asked if they seemed to be on the same wavelength as their partner as the experience was occurring. They also rated whether they shared the same perception of what was happening in the moment.
Following these questions, the participants rated various aspects of their relationship both before and after the psychedelic event using established psychological scales. These everyday characteristics included emotional closeness, spiritual connection, physical intimacy, and general relationship satisfaction. The survey also collected ratings regarding interpersonal tenderness, feelings of commitment, and how often the couple experienced prolonged conflict.
One particular metric of interest was self-other overlap, a concept that measures how much a person feels their own identity merges with their partner’s identity. Survey takers selected visual diagrams depicting varying degrees of overlapping circles to indicate their level of interpersonal closeness before and after the drug experience.
The resulting data supported the research team’s initial hypotheses. Participants who took a psychedelic substance alongside their romantic partner reported vastly more positive behavioral changes than those who engaged in the experience alone. Engaging in the experience together was associated with elevated scores across nearly all relationship categories.
Couples who shared the substance use noted robust improvements in physical and emotional intimacy. They also reported higher levels of collaboration, a greater willingness to see things from their partner’s point of view, and an increased openness to new experiences in life. Notably, the amount of physical time the partners chose to spend together after the event also increased by a noticeable margin.
To understand why these enhancements occurred, the researchers utilized a statistical analysis involving the shared reality questionnaire. They found that a heightened sense of mutual understanding accounted for the positive relational outcomes. Sharing the psychedelic state allowed partners to feel like they were on the exact same wavelength, which in turn boosted their overall relationship satisfaction.
The survey findings also illuminated potential risks for people who did not share their psychedelic journeys. For individuals reporting on past romantic relationships, taking a psychedelic alone was linked to a much lower degree of shared reality regarding the event. This lack of shared understanding was indirectly associated with the decision to eventually end the relationship.
The researchers theorized that undergoing an intense internal transformation without a partner disrupts the couple’s established worldview. While taking the drug alone did not directly break up the partnership, the resulting misalignment in reality perception appeared to act as a stepping stone toward the breakup.
These results hold direct clinical applications for emerging psychiatric treatments. Modern therapies could inadvertently diminish a couple’s shared reality by treating only one member of a relationship. If a patient experiences a major shift in how they view the world, their untreated partner might struggle to relate, creating unintended emotional distance in the home.
At the same time, the authors warned that the profound bonding power of psychedelics requires strict ethical boundaries in clinical settings. In environments dealing with domestic distress, artificially increasing emotional vulnerability could be dangerous. Psychedelic therapies for couples in abusive situations would need robust screening processes to ensure the substances do not trap an individual in an unsafe or coercive dynamic.
The study has several limitations that prevent the researchers from determining strict cause and effect. The cross-sectional design relied entirely on participants recalling past events at a single point in time, which can introduce memory bias. Additionally, asking participants to deliberately rank their most meaningful experience might have skewed the results toward unusually impactful events.
The study sample lacked racial diversity, as nearly eighty percent of the survey takers identified as white. Because the data were entirely observational, it is possible that couples who already possessed strong communication skills were naturally more likely to take a psychedelic together. Experimental studies are necessary to isolate the genuine psychological impacts of the drugs.
Future investigations should track couples chronologically to see if the relationship benefits fade as time passes. Researchers could also explore whether partners need to ingest the exact same substance to reap the rewards, as almost every participant in the current study matched their partner’s drug choice. Looking at objective brain activity, such as neural synchrony during a shared psychedelic state, could provide even deeper insights.
The study, “Associations of Couples’ Psychedelic Use with Shared Reality and Relational Well-Being,” was authored by Talea Cornelius and Tommaso Barba.
